Authors
Latest:
The Role of AI in Helping Clinicians Diagnose PatientsThree ways artificial intelligence can drive the necessary engagement between patients and HCPs.
Latest:
The Emergence of the Chief Value Officer in HealthcareOutlining the implications of this c-suite trend for pharma.
Latest:
The Future of Safety and Adverse Event ProcessesAddressing the increased use of technology in safety compliance processes and greater patient involvement.
Latest:
How Biopharma Can Rev Up the Analytics Engine to Boost Patient ComplianceWhile patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.
Latest:
Partnerships Are Key to Niche Markets in BrazilForging effective partnerships with local companies is particularly important when entering Brazil’s pharma market. Sameer Kolhe reports.
Latest:
Has Pharma Given Up on Long-Term Adherence?Will the FDA ultimately step in and mandate a credible effort to eradicate the mindset that long-term adherence is not achievable?
Latest:
Why Pharma Must Invest in Key Account Management CapabilitiesThe emergence of organized customers demands investment in advanced solutions and next-generation key account management.
Latest:
How to Improve Life Sciences Promotional Review Committees Using Service Operations PrinciplesA deep-dive into how pharma companies can apply service operations principles to achieve a greater level of marketing and promotional review committee satisfaction.
Latest:
Digital-Communication Check: Insights Learned During LockdownA look at the results of recent surveys revealing the impact of the COVID-triggered digital switchover on sales rep interactions and medical conferences.
Latest:
Pharma Forecasting: Key Markets Investors Can’t IgnoreThe importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.
Latest:
Former X CEO Linda Yaccarino Appointed as Chief Executive Officer for eMed Population HealthThe choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative technology.
Latest:
AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma BrandsMarket dynamics boost the need and urgency for more sophisticated benchmarking strategies.
Latest:
To Build AI Maturity, Start With Quick WinsCompanies must determine the right ways to utilize AI.
Latest:
Tuning and Tracking CAR-T Cells for Safer and More Effective Treatment for Solid TumorsWith technological advancements in affinity tuning and real-time tracking of CAR-T cells, the hope is that CAR-T therapy can be effectively applied to treating solid tumors, improve patient outcomes, and avoid the toxicities seen with certain treatments in the clinic.
Latest:
Revenue Optimization: The Money Matters—That Matter MostNavigating technology and regulatory shifts in pharma revenue management.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Enhancing Supply Chain Resilience amid Complexity in Pharma and Medical DevicesThe growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such as S&OP and S&OE.
Latest:
Building the Pharma Talent of Tomorrow from Today’s WorkforceHiring new employees may not be the answer to the war for talent.
Latest:
Abu Dhabi Reinforces Global Leadership in Healthcare Innovation with High-Level US VisitDuring a high-level US visit, the Department of Health—Abu Dhabi signed strategic agreements with Abbott, Boehringer Ingelheim, and Sanofi to boost pharmaceutical manufacturing, expand vaccine development, and advance digital health and clinical research.
Latest:
Future-Ready Leadership: Redefining the Biopharma C-suite for an AI-Driven EraHow will the tasks of C-suite leaders be transformed by intelligent technologies?
